177 related articles for article (PubMed ID: 10576514)
1. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome.
Wan TS; Au WY; Chan JC; Chan LC; Ma SK
Leuk Res; 1999 Nov; 23(11):1079-83. PubMed ID: 10576514
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
4. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.
Paulsson K; Johansson B
Pathol Biol (Paris); 2007 Feb; 55(1):37-48. PubMed ID: 16697122
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1996 Nov; 106(5):676-9. PubMed ID: 8929481
[TBL] [Abstract][Full Text] [Related]
6. Trisomy 6 as a primary karyotypic aberration in hematologic disorders.
Mohamed AN; Varterasian ML; Dobin SM; McConnell TS; Wolman SR; Rankin C; Willman CL; Head DR; Slovak ML
Cancer Genet Cytogenet; 1998 Oct; 106(2):152-5. PubMed ID: 9797781
[TBL] [Abstract][Full Text] [Related]
7. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 11: an association with stem/progenitor cell immunophenotype.
Slovak ML; Traweek ST; Willman CL; Head DR; Kopecky KJ; Magenis RE; Appelbaum FR; Forman SJ
Br J Haematol; 1995 Jun; 90(2):266-73. PubMed ID: 7794746
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms.
Johansson B; Billström R; Mauritzson N; Mitelman F
Cancer Genet Cytogenet; 1994 May; 74(1):62-5. PubMed ID: 8194050
[TBL] [Abstract][Full Text] [Related]
11. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B
Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379
[TBL] [Abstract][Full Text] [Related]
14. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
[TBL] [Abstract][Full Text] [Related]
17. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
18. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
19. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
Washington LT; Doherty D; Glassman A; Martins J; Ibrahim S; Lai R
Leuk Lymphoma; 2002 Apr; 43(4):761-5. PubMed ID: 12153162
[TBL] [Abstract][Full Text] [Related]
20. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
